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A B S T R A C T
Pancreatic diﬀerentiation of stem cells will aid treatment of patients with type I diabetes mellitus (T1DM).
Synthetic biopolymers utilization provided extracellular matrix (ECM) and desired attributes in vitro to enhance
conditions for stem cells proliferation, attachment and diﬀerentiation. A mixture of polycaprolactone and
polyvinyl alcohol (PCL/PVA)-based scaﬀold, could establish an in vitro three-dimensional (3D) culture model.
The objective of this study was investigation of the human induced pluripotent stem cells (hiPSCs) diﬀer-
entiation capacity to insulin-producing cells (IPCs) in 3D culture were compared with conventional culture (2D)
groups evaluated at the mRNA and protein levels by quantitative PCR and immunoﬂuorescence assay, respec-
tively. The functionality of diﬀerentiated IPCs was assessed by C-peptide and insulin release in response to
glucose stimulation test. Real-Time PCR results showed that iPSCs-IPCs expressed pancreas-speciﬁc transcription
factors (Insulin, Pdx1, Glucagon, Glut2 and Ngn3). The expressions of these transcription factors in PCL/PVA
scaﬀold were higher than 2D groups. In addition to IPCs speciﬁc markers were detected by immunochemistry.
These cells in both groups secreted insulin and C-peptide in a glucose challenge test by ELISA showing in vitro
maturation. The results of current study demonstrated that enhanced diﬀerentiation of IPCs from hiPSCs could
be result of PCL/PVA nanoﬁbrous scaﬀolds. In conclusion, this research could provide a new approach to beta-
like cells replacement therapies and pancreatic tissue engineering for T1DM in the future.
1. Introduction
Diabetes mellitus is a group of metabolic diseases in which, for
diﬀerent reasons, glucose levels are higher than typical levels.
According to statistics indicated by the American Diabetes Association
diabetes is the seventh leading reason for death in the United States and
unfortunately, its prevalence is expanding (Rathmann and Giani, 2004;
Association AD, 2016). Type I diabetes mellitus (T1DM) which
comprises 5–10% of diabetes, results from immune system destruction
of pancreatic beta-like cells and pancreas's inability to produce enough
insulin (Abdulazeez, 2015).
Recently, much research has sought to apply stem cells to diﬀer-
entiate beta-like cells and focus on the generation and development of
these alternative sources (Shen et al., 2013; Piran et al., 2017; Enderami
et al., 2017a). Meanwhile, induced pluripotent stem cells (iPSCs), be-
cause of their high capability of self-renewability and diﬀerentiation as
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well as low immunogenicity, are a suitable cell source for use in elective
therapies (Takahashi et al., 2007). Human iPSCs can be expanded in
vitro and by utilizing growth factors and transcription elements that
recapitulate expansion of pancreatic cells, can be diﬀerentiated to in-
sulin-producing cells (IPCs) (Enderami et al., 2017a; Enderami et al.,
2017b; Mansour et al., 2018). Therefore, many studies have stated that
iPSCs can eﬀectively diﬀerentiate into beta-like cells in the 2D culture
(Enderami et al., 2017a; Lahmy et al., 2014; Kondo et al., 2017). In
recent years, much research have tried to apply cell-based therapy for
T1DM (Aghazadeh and Nostro, 2017). To get the cells required for cell
therapy; these studies have used diﬀerent strategies, such as the use of
diﬀerentiation medium and gene transfer for the diﬀerentiation of stem
cells into beta-like cells (Chen et al., 2009; Raikwar and Zavazava,
2012; Zhang et al., 2009; Wei et al., 2013). These procedures are costly
and time consuming. In order to circumvent these problems, a novel
approach must be improved.
Several studies have demonstrated that the use of three-dimensional
(3D) environments can be a strategy to overcome the limitations of
current beta-like cells production methods (Aloysious and Nair, 2014;
Amer et al., 2014). Recent advances in tissue engineering and re-
generative medicine have empowered the control of cells through the
scaﬀolds made of biodegradable and biocompatible polymers. In the
ﬁeld of biomaterials, these materials rapidly adjust to the human body
and do not stimulate the immune system (Ellis et al., 2017; Greggio
et al., 2013; Ravi et al., 2015).These platforms give a 3D environment
that improves the diﬀerentiation of stem cell types into beta-like cells
(Enderami et al., 2017b). It appears that these 3D nanoﬁber scaﬀolds,
by imitating in vivo condition, support the cell-extracellular matrix
(ECM) interactions and in addition the cell-cell contacts (Mahboudi
et al., 2018). Many synthetic polymers have been used to fabricate
nanoﬁbers. In the present study, we plan to utilize an adaptable, bio-
compatible, biodegradable and hydrophilic polymer as a suitable sub-
strate for diﬀerentiating iPSCs into beta-like cells. Polycaprolactone and
polyvinyl alcohol (PCL/PVA)-based scaﬀold may indicate biological
properties and give suitable synthetic ECM for the improvement pan-
creatic beta-like cells diﬀerentiation and islet organization. PCL is
biocompatible and biodegradable polyester with hydrophobicity char-
acteristic and high mechanical stability which has been intensively
studied as a good candidate for fabrication of 3D culture (Xue et al.,
2014; Zarekhalili et al., 2017). However, cell aﬃnity of PCL is poor.
Thus, this synthetic polymer does not have favorable property, and PVA
is a biodegradable polymer with low toxicity, inexpensive and hydro-
philic polymer with thermal stability and good mechanical. This bio-
polymer has been used for tissue engineering and biomedical applica-
tions (Zarekhalili et al., 2017; Maheshwari et al., 2013). Specially, to
our knowledge, there is no study to evaluate the pancreatic diﬀer-
entiation of iPSCs on PCL/PVA scaﬀold. With this background, the aim
of our study is to evaluate whether iPSCs seeded on PCL/PVA scaﬀold
compared to tissue culture plates (TCPS) may enhance diﬀerentiation
toward pancreatic lineages. To this purpose, we studied the eﬀects of
3D culture on viability and expression of pancreatic-speciﬁc genes in-
cluding insulin, glucagon, pdx1, ngn3 and glut2. The results showed
that PCL/PVA scaﬀold compared 2D culture can provide a good pan-
creatic diﬀerentiation condition for iPSCs and generate the IPCs.
2. Materials and methods
2.1. Expansion of induced pluripotent stem cells
Human iPSC lines were given by Prof. Masoud Soleimani of Stem
Cells Technology Research Center that previously characterized and
reported (Ardeshirylajimi et al., 2014). The use of human iPSC was
approved by the Ethics Committee of Shahid Beheshti University of
Medical Sciences (Tehran, Iran). Human iPSCs were cultured and ex-
panded on a mouse embryonic ﬁbroblast (MEF) feeder cell layer in-
activated with mitomycin-C (Sigma) in iPSCs medium (DMEM/F12
supplemented with 20% knockout serum replacement, 2 mM L-gluta-
mine, 0.1mmol/l nonessential amino acids, 0.1 mM β-mercaptoethanol
and 10 ng/ml of recombinant human basic ﬁbroblast growth factor
(bFGF), all from Invitrogen) in a 5% CO2 and 95% humidity. Every
3–5 days, human iPSC colonies were passaged enzymatically using
0.1% Collagenase type IV (Invitrogen), and transferred onto inactivated
MEF for expansion (Enderami et al., 2017a).
2.2. Scaﬀold fabrication
Nanoﬁbrous PCL/PVA scaﬀolds were fabricated and Produced by an
electerospinning method. Amount 0.8 g of PCL polymer was broken
down in 9ml of chloroform and 1ml of dimethylformamide and 1.2 g of
PVA polymer were dissolved in 10ml of high temp water. Next, solu-
tions were loaded into two 10ml plastic syringe and placed across the
collector at a ﬁxed distance of 18 cm. Electrospinning process was done
at a ﬂow rate of 1ml/h, under a positive voltage of 23 kV amongst
needle and collector (Enderami et al., 2018).
2.3. Surface modiﬁcation
After nanoﬁbrous scaﬀold fabrication, to optimize the hydro-
philicity, surface plasma treatment of PCL/PVA scaﬀolds was done
under optimized states previously (Ardeshirylajimi et al., 2013), in
brief, of 40 kHz low frequency at 30 w with a cylindrical quartz reactor
(Diener Electronics, Germany) by bring pure oxygen into the reaction
chamber at 0.4mbar pressure and then the glow discharge was per-
formed for 5min.
2.4. Scanning electron microscopy
The cell-polymer constructs were ﬁxed in 2.5% glutaraldehyde
(45min). The ﬁxed samples were ﬂushed two times with PBS for 5min;
after that they dehydrated in ethanol arrangement (50%, 60%, 70%,
80%, 95% and 100% v/v) for 5min each and dried. The dried nanoﬁ-
brous scaﬀolds mounted onto aluminum sample holders with Araldite
TM glue and covered with palladium gold in a sputter-coater (Hitachi,
Tokyo, Japan). Then, the samples were observed utilizing a scanning
electron microscope (SEM; Hitachi S-4500, Japan).
2.5. Cell seeding on scaﬀolds
In order to sterilization, the PCL/PVA scaﬀolds were punched to the
coveted size and sterilized under ultraviolet light for 30min. Then
scaﬀolds were ﬂushed with PBS and were put overnight in the base
medium supplemented with 10% serum at 37 °C. Before diﬀerentiation,
in order to embroid body (EB) generation, human iPSCs colonies were
detached enzymatically using 0.1% Collagenase type IV (Invitrogen)
and transferred to non-adherent culture plate in EB medium (iPSC
medium without bFGF) for 5 days. Shaped EBs plated on PLLA/PVA
scaﬀolds at a density of 5.0× 104 cells per each scaﬀold in MEF-
adapted medium for 2 days.
2.6. Experimental design
Four groups including 2 control and 2 experimental groups were
considered. The hiPSCs were seeded onto the PCL/PVA scaﬀolds in
iPSCs media and utilized as the 3D control group. The hiPSCs were
cultured in tissue culture ﬂask under iPSCs media as the 2D control
group. The cultured hiPSCs in IPCs diﬀerentiation media were utilized
as the 2D experimental group. The hiPSCs were seeded onto the PCL/
PVA scaﬀolds in IPCs diﬀerentiation media and considered as the 3D
experimental group. A three-step diﬀerentiation protocol was utilized
to induce hiPSCs into IPCs. At Step 1: the hiPSCs were seeded (37 °C,
5% CO2) for 7 days in the medium I containing serum-free high glucose
DMEM (25mmol/l), 0.5 mmol/l beta-mercaptoethanol (Invitrogen) and
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50 ng/ml activin A (Sigma). Next, in step 2: the hiPSCs were cultured in
the diﬀerentiation medium II containing 20 ng/ml basic ﬁbroblast
growth factor (bFGF; Sigma), 20 ng/ml epidermal growth factor (EGF;
Sigma), 1% nonessential amino acids (Invitrogen), 2 mmol/L L-gluta-
mine (Sigma), and 10 ng/ml exendine-4 (Sigma), 2% B27 (Invitrogen)
for 7 days. Then, in Step 3: the hiPSCs were treated for an additional
7 days in diﬀerentiation medium III containing 2% B27, 10 ng/ml be-
tacellulin (Sigma), 10mmol/l nicotinamide (Sigma), and 10 ng/ml ex-
endine-4. The diﬀerential media was replaced with new medium every
2 days.
2.7. Cell proliferation assay
MTT assay was utilized to investigate the proliferation ability and
viability of iPSCs on PCL/PVA scaﬀold for 3 days. Brieﬂy, sterilized
nanoﬁbrous membranes were seeded in a 48-well cell culture plate,
cultured at a cell density of 4×103 cells/cm2 and incubated at 5% CO2,
37 °C. At 24, 48 and 72 h after seeding hiPSCs, 50 μl MTT reagent (3-[4,
5-dimethyl-thiazolyl-2]-2, 5-diphenoltetrazolium bromide) with a con-
centration of 5mg/ml in DMEM was added to each well. After 3 h in-
cubation, the formazan crystals were solubilized with dimethylsulf-
oxide (DMSO). Then, Plates were shaken to dissolve the precipitate. The
sample absorbance was evaluated by absorbance measurement at
570 nm utilizing a BioTek Synergy HT micro-plate reader (BioTek
Instruments Inc., USA). This assay was performed in triplicate in-
dependently.
2.8. RNA extraction and quantitative Real-Time PCR
Total RNA was isolated from control cells and diﬀerentiated hiPSCs
at the end of the induction procedure with the RNeasy Mini Kit
(Qiagen) following the manufacturer's instruction. Next, total RNA was
reverse transcribed with the random hexamer primer to complementary
DNA (cDNA) at 42 °C for 60min and 70 °C for 5min in a total reaction
volume of 15 μl using M-MuLV Reverse Transcriptase kit (Fermentas).
Quantitative Real-Time PCR was performed according to the manu-
facturer's protocol and with the ABI Light Cycler (ABI step one) in a
total reaction volume of 10 μl in 96-well optical reaction plates using a
SYBR premix ExTaq (Takara, Korea). The primer sequences were de-
signed by AlleleID software (Primer Biosoft), which is shown in Table 1.
All reactions were completed at 95 °C for 2min, followed by 40 am-
pliﬁcation cycles in triplicate, and the data were normalized against the
Ct value of the endogenous β2m. The relative quantiﬁcation (2−ΔΔCt)
method was utilized to analyze the data.
2.9. Immunoﬂuorescence assay
The diﬀerentiated iPSCs in both 2D and 3D groups and control
groups were ﬁxed with 4% (w/v) paraformaldehyde (Sigma) at 4 °C for
30min in end stages of the diﬀerentiation process. All samples were
permeabilized with 0.2% triton X-100 (Sigma) and blocked with 10%
goat serum (Sigma) for 1 h at RT. For maturation stage primary anti-
body against insulin (1:200; #ab181547) and for deﬁnitive endoderm
stage, primary antibody against human Pdx1 (1:2000; #ab47267) were
diluted with 1% BSA in PBS. Then, all samples incubated overnight
with these primary antibodies at 4 °C. Next, samples were incubated
with Fluorescein isothiocyanate-labeled secondary antibodies for
90min at RT in darkness. Finally, the nuclei were stained with 0.1 μg/
ml DAPI (Sigma) for 5min. Images were captured using a phase con-
trast ﬂuorescent microscope (Nikon.US). The immunocytochemistry
images were imported to ImageJ software (Version 1.45s, NIH, USA) for
creation of quantity data.
2.10. Insulin and C-peptide release and insulin content assay
The diﬀerentiated iPSCs in both 2D and 3D groups and control
groups were washed 2 times with PBS and were pre-incubated in
Krebs–Ringer bicarbonate (KRB) buﬀer containing 25mM NaHCO3,
1.1 mM MgCl2, 2.5 mM CaCl2, 5mM KCl, 120mM NaCl, and 0.1% BSA
(all from Sigma) in glucose-free for 2 h. Then, diﬀerentiated cells and
control groups were incubated for 2 h in KRB buﬀer with diﬀerent
concentrations of glucose. The supernatant was collected and frozen at
−70 °C until the time of analyzation. To estimation of insulin and C-
peptide secretion, the Ultrasensitive ELISA kit (#10-1132-01, #10-
1141- 01, Mercodia, Uppsala, Sweden) was used according to the
manufacturer's instructions. In addition to measurement of intracellular
insulin, the cells were washed three times with PBS, extracted in 0.2ml
acid alcohol (10% glacial acetic acid in absolute ethanol) at 4 °C
overnight, and then cells were subsequently sonicated three times 15 s
each at 40–60w, and centrifuged (13.000 rpm, 15min, 4 °C). Then, the
supernatant was collected and stocked at −70 °C until being assayed.
Total protein concentration was determined by the BCA protein assay
system and 50 μg of protein was used for detection of intracellular in-
sulin in each well of ELISA kit. This assay was done for six times.
2.11. Statistical analysis
All experiments were done for several times, and the obtained data
were reported as Mean ± SEM (standard error mean). Results were
analyzed by one-way ANOVA, and Bonferroni's post-hoc test was uti-
lized for comparison of 2D and 3D groups by Graphpad Prism 6 soft-
ware (Graphpad Software Inc., La Jolla, CA, USA). In between the
compared groups, a P-value of< 0.05 was considered statistically sig-
niﬁcant.
3. Results
3.1. Morphological changes of hiPSCs diﬀerentiation into IPCs
To produce IPCs from hiPSCs, we used a formerly reported stepwise
Table 1
Speciﬁcations of primer sequences used for quantitative real-time PCR.
Human genes Primer sequence Annealing temperature (°C) Product size (bp)
Pdx1 Forward: 5′-ATGGATGAAGTCTACCAAAGC-3′ 60 159
Reverse: 5′-CGTGAGATGTACTTGTTGAATAG-3′
Glut2 Forward: 5′-TCACTGCTGTCTCTGTATTCC-3′ 60 147
Reverse: 5′-TGCTCACATAACTCATCCAAG-3′
Ngn3 Forward: 5′-AGAGAGCGTGACAGAGGC-3′ 60 182
Reverse: 5′-GCGTCATCCTTTCTACCG-3′
Gcg Forward: 5′-ACCAGAAGACAGCAGAAATG-3′ 59 191
Reverse: 5′-GAATGTGCCCTGTGAATG-3′
Insulin Forward: 5′-GCTTCTTCTACACACCCAAG-3′ 60 171
Reverse: 5′-GGTAGAGGGAGCAGATGC-3′
β2m Forward: 5′-ATGCCTGCCGTGTGAAC-3′ 60 91
Reverse: 5′-ATCTTCAAACCTCCATGATG-3′
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diﬀerentiation process that followed human pancreatic beta-like cells
formative principles with a few modiﬁcations, such as obtaining IPCs in
a quick time of diﬀerentiation. Under the scanning electron microscope
and inverted microscope, the diﬀerentiation of hiPSCs into beta-like
cells and cell morphologies were recorded at the end of diﬀerentiation
stages (Figs. 1, 2). SEM images displayed that the PCL/PVA nanoﬁbrous
scaﬀold was very porous and contained a various interconnected pores
(Fig. 2a). After the hiPSCs were seeded in plates and on the scaﬀolds
and following serial addition of diﬀerentiation medium I, II and III for
21 days, hiPSCs altered to sheets of cells and occupied the pores of the
PCL/PVA scaﬀolds in both control and experimental 3D culture. In the
control group, hiPSCs took a stretched and ﬂat shape (Fig. 2b); while
the diﬀerentiated cells in the experimental group were bunch formed
structure which is a usual morphological feature of pancreatic islet
(Fig. 1b, 2c). Finally, these bunch formed structures were used for
further assessment to test the eﬃciency of diﬀerentiation protocol in
various groups.
3.2. Cell viability assessment
MTT test showed biocompatibility of PCL/PVA scaﬀolds and its
eﬀectiveness in supporting cell viability. As shown in Fig. 3, the pro-
liferation rate of the hiPSCs on nanoﬁbrous was signiﬁcantly higher
than the 2D culture group. Cell viability on scaﬀolds show that in-
creased compared with the sample of 2D culture on 5th and 7th days;
however, on 1th and 3rd days of the culture, the cell viability on
scaﬀolds did not increase compared with 2D culture group.
3.3. Gene expression pattern of pancreatic endocrine genes
To demonstrate whether the hiPSCs had diﬀerentiated into IPCs,
Real-Time PCR analysis was performed to investigate endocrine genes
expression proﬁles for pancreatic cell markers in the mRNA level. Since
genes expression analysis indicated no signiﬁcant diﬀerences between
the two controls, both of them were considered as one group. As in-
dicated in Fig. 4, the expression of Glut2, Ngn3, Insulin, Glucagon, and
Pdx1 genes in undiﬀerentiated hiPSCs, as a control group, was low.
After the hiPSCs diﬀerentiated into beta-like cells, Real-Time PCR
analysis showed that the expression pattern of endocrine genes was
signiﬁcantly increased in the 2D culture of hiPSCs-derived IPCs in
comparison with control group (undiﬀerentiated hiPSCs). High ex-
pression of endocrine genes was detected in the cells cultured and
diﬀerentiated on the PCL/PVA scaﬀold. HiPSCs-derived IPCs indicated
a signiﬁcant increase in Pdx1, Glucagon, Ngn3, and Insulin gene ex-
pression when they cultured in nanoﬁbrous scaﬀolds compared to the
2D culture. Overall, these results indicated that the presence of a
Fig. 1. Morphological changes in 2D culture. (a) hiPSCs in DMEM (control group). (b) hiPSCs in IPC diﬀerentiation media. Scale bars are 100 μm.
Fig. 2. Morphological changes in 3D culture. (a) Unseeded scaﬀold. Interconnected pores are observed. (b) hiPSCs-seeded scaﬀold in DMEM (control group). The
cells show spindle-shape morphology. (c) hiPSCs-seeded scaﬀold in IPC diﬀerentiation media. The cells form spherical clusters of round cells. Scale bars are a, b and
c: 10 μm.
Fig. 3. MTT cell proliferation assay of hiPSCs on PCL/PVA scaﬀold (3D) and
tissue culture polystyrene (2D) during 1, 3, 5 and 7 days of culture. *P-
value < 0.05.
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scaﬀold along with the induction media could conduct to eﬀective
diﬀerentiation of hiPSCs to beta-like cells and PCL/PVA nanoﬁbrous
scaﬀolds as a synthetic polymer can enhance and improve IPCs diﬀer-
entiation.
3.4. Immunoﬂuorescence staining
To conﬁrm pancreatic diﬀerentiation of hiPSCs into beta-like cells in
the protein level, expression pancreatic-speciﬁc markers (Pdx1 and
Insulin) was investigated by the immunostaining assay (Fig. 5a, b).
Immunocytochemistry did not see any Insulin and Pdx1 genes expres-
sion in 3D and 2D control groups (data not shown). In the 2D experi-
mental culture group, Weak or moderate expression of Insulin and Pdx1
was detected in the cytoplasm and nuclei, respectively, in diﬀerentiated
IPCs on day 21. In a 3D experimental group, strong immune-reactivity
of both markers was seen in the cytoplasm and nuclei of diﬀerentiated
IPCs on day 21. Qunter-staining of the nucleus (blue) was done by
DAPI. These results are displayed in Fig. 5a, b. The qualitative results of
the immunostaining assay were quantitatively conﬁrmed by ImageJ
software (Fig. 5c).
3.5. Insulin and C-peptide release and insulin content in response to glucose
stimulation
In order to evaluate the ability of diﬀerentiated cells, insulin and C-
peptide secretion of hiPSC-IPCs in response to various concentrations of
glucose were done by utilizing an ELISA kit. The secretion of cultured
hiPSCs in control groups detected very low levels of C-peptide and in-
sulin in the exposure low or high of glucose concentrations. Both de-
rived IPCs mediated through the procedure with 3D and 2D culture did
not have a signiﬁcant response to concentrations of glucose challenge
from 5.5 to 15mM compared to each other (P-value > 0.05). However,
in diﬀerentiated cells with 3D and 2D culture, amounts of insulin se-
cretions were increased by a concentration of 25mM glucose, released
8.83 ± 0.65 and 6.1 ± 0.45 ng/106 cells (n= 6) per 60min and the
amounts of C-peptide were 41.3 ± 2.45 pmol/l and
32.6 ± 2.51 pmol/l (n= 6) respectively. Thus, our data in Fig. 6a, b
indicated that diﬀerentiated cells with 3D culture in the concentration
of 25mM glucose challenge could signiﬁcantly produce more insulin
and C-peptide compared to diﬀerentiate cells with 2D culture (P-
value < 0.05, P-value < 0.01). Moreover, the insulin content in iPSCs-
derived IPCs was measured. The values for insulin in 5.5, 15 and 25mM
glucose concentrations in 2D group were 7.3 ± 3.5 ng/mg,
9.16 ± 2.32 ng/mg, 24.18 ± 1.8 ng/mg and values in 5.5, 15 and
25Mm glucose for 3D group were 11.2 ± 1.2 ng/mg, 17.3 ± 4.4 ng/
mg, 34.3 ± 1.2 ng/mg respectively. Thus, the obtained results con-
ﬁrmed that maturated iPSCs-derived IPCs in 3D group could produce
signiﬁcant amount of insulin as compared to 2D group (P-value < 0.5).
These results are shown in Fig. 6c.
4. Discussion
The connection between extracellular matrix and islets is vital for
islet function and survival. In a 2D culture (TCPS) of beta-like cells, low
cell–matrix connection between cells and less spherical morphology of
cells were reported. The beta-like cells require a suitable micro-
environment for maintaining its spherical architecture, function and
viability, which could be provided by a favorable nanoﬁbrous scaﬀold.
In the present study, we used PCL/PVA scaﬀold as a substrate for dif-
ferentiation of iPSCs into beta-like cells. To evaluate the eﬀect of this
scaﬀold on iPSCs during pancreatic diﬀerentiation, we seeded the iPSCs
in 3D culture (nanoﬁbrous scaﬀolds) and TCPS with induction medium
and further assessed cell morphology and function.
In order to induce IPCs, in this study, we used reagent growth fac-
tors such as bFGF, EGF, Activin-A and betacellulin. EGF and bFGF play
an important role in cellular proliferation, survival and diﬀerentiation.
EGF and bFGF, have been shown to be useful in IPCs diﬀerentiation
(Lumelsky et al., 2001). Hardikar et al. reported that, several diﬀer-
entiation factors and growth factors tested on pancreatic progenitor
cells, bFGF secreted by endocrine cells was found to be the chemo-at-
tractant in the clustering of precursor cells (Hardikar et al., 2003).
Activin proteins belong to the transforming growth factor-beta (TGF-β)
superfamily. Activin-A can enhance and regulate a wide range of bio-
logical activities including glucose-stimulated insulin secretion in beta-
cells from humans and rats in culture (Florio et al., 2000).
The invert and electron microscope images displayed, in both
groups, during diﬀerentiation progression, the morphology of cells
regularly changed and ultimately hiPSC-IPCs converted spherical-
shaped cell that was the usual shape of islets of Langerhans. The
milestone of our data along with our other study was 3D morphology of
iPSCs-IPCs in nanoﬁberous scaﬀold at the end of stages that was com-
pletely similar to spherically shaped islets of Langerhans (Enderami
et al., 2017b). This morphology has not seen in same studies during
same periods (Khorsandi et al., 2015a). Our immunostaining analysis
indicated the expression of insulin and Pdx1 in iPSCs-IPCs cultured on
nanoﬁberous scaﬀold qualitatively and quantitatively were higher than
2D culture. These results reveal that PCL/PVA scaﬀold could improve
homogenous and eﬃcient diﬀerentiation iPSCs into beta-like cells. The
induction of these expressions of endocrine markers during diﬀer-
entiating iPSCs on this scaﬀold, were also detected by our quantitative
PCR analysis. When we focused on the expression of endocrine-speciﬁc
transcription factors, we noticed the diﬀerence between 3D and 2D
groups was statistically signiﬁcant in endocrine speciﬁc markers in
mRNA and protein level. The expression of Glucagon, Insulin, Pdx1,
Ngn3 genes in 3D culture were signiﬁcantly higher than 2D cultures,
but about Glut-2 gene as a beta cell maturity marker, although this
glucose transporter gene was expressed in both groups, there was no
statistically signiﬁcant diﬀerence between them. This result aligned
with Enderami et al.'s study in 2017 (Enderami et al., 2017a). For this
reason, the results (Fig. 6a, b) revealed that the diﬀerentiated cells
secretions in response to the low level of glucose (5.5 mM) concentra-
tion between both experimental groups were not signiﬁcant. We
documented insulin secretion from diﬀerentiated iPSCs into beta-like
cells after the cells were exposed to 5.5_25mM glucose. However, the
previous study indicated that glucose concentration (at 20–30mM) is a
potent stimulator for IPCs by secreting insulin in vitro (Aloysious and
Nair, 2014). In agreement with the previous study that gelatin/dextran
nanoﬁbrous scaﬀold was used for diﬀerentiation of adipose stem cells
to beta-like cells, our results showed that PCL/PVA promotes
Fig. 4. Relative gene expression in end stage derived IPCs. The expression le-
vels of pancreatic transcription factors such as Pdx1, Ngn3, Insulin, Glucagon,
and Glut2 were analyzed at each group of diﬀerentiation into IPCs. Gene
transcripts of 3D group are compared 2D group. Relative levels of gene ex-
pression were normalized to the human β2M. The value is shown in each graph
as mean ± SEM. *P-value < 0.05, **P-value < 0.01 and ****P-value <
0.0001.
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diﬀerentiation of glucose-responsive beta-like cells from iPSCs. In this
study, a signiﬁcant increase in the secretion of insulin upon glucose
stimulation in PCL/PVA nanoﬁbrous scaﬀold iPSCs derived IPCs in
comparison to TCPS was recognized. This ﬁnding describes that mature
IPCs can be generated from iPSCs in 3D cultures. Khorsandi et al.'s
reported that, compared to adipose-derived mesenchymal stem cell-
derived IPCs in the 2D culture, the insulin release from mesenchymal
stem cell-derived IPCs in the 3D culture showed a nearly 3.8-fold in-
crease when exposed to a high glucose concentration (Khorsandi et al.,
2015b). In our study, iPSCs-derived IPCs in the 3D culture indicated
1.5-fold increases in the insulin secretion compared to the 2D culture of
iPSCs-derived IPCs. In the present study, the showed results of endo-
crine lineage markers expression in mRNA and protein level evaluation
were aligned with the other studies in the ﬁeld of stem cell diﬀer-
entiation to beta-like cells (Enderami et al., 2017b; Lahmy et al., 2014;
Khorsandi et al., 2015b).
The exact cellular and molecular events that PCL/PVA scaﬀold ex-
erts on iPSCs during diﬀerentiation to beta-like cells were not evaluated
in this study. However, previous studies have revealed that 3D culture
conditions increase global gene expression, cell diﬀerentiation, cell
viability and proliferation. It has been reported that in 3D culture, this
cellular behavior may be related to physiological conditions and in-
teractions of seeded cells with an extracellular matrix and neighboring
cells (Meng et al., 2014; Page et al., 2013). Besides the increase in the
expression of endocrine genes, Baharvand et al., have revealed cellular
organelles involved in protein synthesis and secretion also increase in
the 3D culture (Baharvand et al., 2004). Several studies indicated the
high potential application of electrospun nanoﬁbers fabricated from
various synthetic polymers in combination with a variety of stem cells
in pancreatic tissue engineering (Enderami et al., 2017b; Fazili et al.,
2016; Hoveizi et al., 2014).
The result suggests that the nanoﬁbrous scaﬀold eﬃciently mimics
the role of ECM by preparing a positive environment for IPCs. This
condition obtainable by the nanoﬁbrous scaﬀold is due to the presence
of biocompatible and biodegradable polymer, the good porosity and
lack of toxic agents. The PCL/PVA nanoﬁbrous scaﬀold is more favor-
able for maintaining the structure and morphology, thereby enhancing
the function and survival of IPCs.
In summary, the results of this study introduced a new approach for
the diﬀerentiation of hiPSCs to beta-like cells with PCL/PVA scaﬀold for
the ﬁrst time. Diﬀerentiation in this scaﬀold system is much more ef-
ﬁcient than monolayer culture system in the mRNA and protein levels,
insulin and C-peptide secretion, and response to glucose challenge test.
In addition, this nanoﬁbrous scaﬀold could be a feasible alternative to
ECM and be very useful for pancreatic tissue engineering. However,
more research is required to investigate the exact cellular and mole-
cular mechanisms of this scaﬀold function in vivo.
Fig. 5. Immunocytochemical analysis in end stage derived IPCs. Immunoﬂuorescence analysis detected nuclei localization of Pdx1, and cytoplasmic localization of
Insulin in diﬀerentiated IPCs at day 14 in the 2D group (a) and 3D group (b). Counter-staining of nucleus (blue) was performed by DAPI. Bar graph quantiﬁcation of
the immunocytochemistry assay. Each bar represents the relative value of insulin and Pdx1 markers, diﬀerences were observed between 3D and 2D groups. Scale bars
are 100 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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